Compare CTKB & CLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTKB | CLB |
|---|---|---|
| Founded | 1990 | 1936 |
| Country | United States | United States |
| Employees | N/A | 3300 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 541.1M | 502.0M |
| IPO Year | 2021 | 2023 |
| Metric | CTKB | CLB |
|---|---|---|
| Price | $5.64 | $10.38 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 2 |
| Target Price | $5.63 | ★ $12.50 |
| AVG Volume (30 Days) | ★ 1.1M | 421.8K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | $193,015,000.00 | ★ $526,520,000.00 |
| Revenue This Year | $5.42 | N/A |
| Revenue Next Year | $7.03 | $4.75 |
| P/E Ratio | ★ N/A | $95.36 |
| Revenue Growth | ★ 17.67 | 0.51 |
| 52 Week Low | $3.28 | $9.79 |
| 52 Week High | $6.18 | $20.36 |
| Indicator | CTKB | CLB |
|---|---|---|
| Relative Strength Index (RSI) | 73.49 | 24.27 |
| Support Level | $4.17 | $9.79 |
| Resistance Level | $6.04 | $12.27 |
| Average True Range (ATR) | 0.24 | 0.45 |
| MACD | 0.09 | -0.21 |
| Stochastic Oscillator | 88.64 | 2.35 |
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.